Surveillance: Optimizing Performance to Meet Infection Prevention and ADE Compliance

Tina Moen, PharmD, Chief Clinical Officer, Clinicians, Thomson Reuters Healthcare. Surveillance and reporting of clinical data for Infection prevention (IP) and Adverse Drug Event (ADE) intervention can represent a significant and ongoing resource drain on clinical and IT staff. And, with Stage 2 Meaningful Use criteria recommending that evidence-based Clinical Decision Support (CDS) be available to point-of-care clinicians once IP and intervention opportunities are identified; an approach that impacts patient care and meets compliance and reporting obligations is ever more difficult to accomplish with your EMR alone. During this presentation, Dr. Moen discusses how an organizational approach that ties system or facility-wide Quality Initiatives and Compliance Goals to discreet objectives for specific departments, such as Infection Prevention and Pharmacy, is a more efficient, clinically consistent and cost effective approach for surveillance and reporting. She also discusses how using evidence-based clinical decision support as part of a patient profiling and alert system, integrated with your EMR, that can enable electronic compliance reporting to NHSN and help your clinicians achieve pro-active intervention and care optimization across care disciplines.